Explore

Trendline Trendline
4Moving Biotech Receives FDA Fast Track Designation for Knee Osteoarthritis Drug

4Moving Biotech Receives FDA Fast Track Designation for Knee Osteoarthritis Drug

4Moving Biotech Receives FDA Fast Track Designation for Knee Osteoarthritis Drug
Trendline Trendline
FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment

FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment

FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment
Trendline Trendline
Inhibrx to Provide Clinical Update on Ozekibart for Colorectal Cancer in Webcast

Inhibrx to Provide Clinical Update on Ozekibart for Colorectal Cancer in Webcast

Inhibrx to Provide Clinical Update on Ozekibart for Colorectal Cancer in Webcast
Trendline Trendline
Precision BioSciences to Present New Data on PBGENE-HBV at EASL Congress 2026

Precision BioSciences to Present New Data on PBGENE-HBV at EASL Congress 2026

Precision BioSciences to Present New Data on PBGENE-HBV at EASL Congress 2026
Trendline Trendline
Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment

Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment

Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment
Trendline Trendline
Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results

Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results

Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results
Trendline Trendline
Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results

Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results

Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results
Trendline Trendline
Ionis Pharmaceuticals Advances Antisense Drug for Rare Neurological Disease

Ionis Pharmaceuticals Advances Antisense Drug for Rare Neurological Disease

Ionis Pharmaceuticals Advances Antisense Drug for Rare Neurological Disease
Trendline Trendline
Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation
Trendline Trendline
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence

Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence

Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Reuters Reuters
US FDA approves Merck's pill combo to treat HIV infection

US FDA approves Merck's pill combo to treat HIV infection

April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the health regulator's website showed on Tuesday.
Trendline Trendline
FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy